Meds & supplements › Pimavanserin
Medicine
NUPLAZID ® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Pimavanserin capsule is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
The following serious adverse reactions are discussed elsewhere in the labeling:
Pimavanserin is contraindicated in patients with a history of a hypersensitivity reaction to pimavanserin or any of its components. Rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea) have been reported [ see Adverse Reactions ].
sofidex [Internet]. Daloreum; c2026. Pimavanserin; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/pimavanserin
sofidex. (2026, August 3). Pimavanserin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/pimavanserin
Pimavanserin. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/pimavanserin
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.